Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTC4S | Q16873 | 18/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.36 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9988043 | 0.90 | LTC4S (0.45) | LTC4SP2RX7P4HTM | |
| SCHEMBL240304 | 0.90 | LTC4S (0.42) | LTC4S | |
| SCHEMBL239167 | 0.84 | LTC4S (0.39) | LTC4S | |
| SCHEMBL250947 | 0.84 | LTC4S (0.44) | LTC4SP2RX7 | |
| SCHEMBL237439 | 0.83 | LTC4S (0.39) | LTC4SP2RX7P4HTM | |
| SCHEMBL238179 | 0.79 | LTC4S (0.41) | LTC4SP4HTM | |
| SCHEMBL237853 | 0.76 | P4HTM (0.46) | LTC4SP4HTM | |
| SCHEMBL238180 | 0.75 | LTC4S (0.66) | LTC4S | |
| SCHEMBL240031 | 0.75 | LTC4S (0.42) | LTC4SP2RX7 | |
| SCHEMBL1722596 | 0.70 | CNR1 (0.36) | LTC4SP2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004244-A1 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors | BIOLIPOX AB (SW) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004244-A1 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors | LTC4S, LTB4R2, LTB4R | LTC4S 1/4885P2RX7 1398/4885P4HTM 403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.